Literature DB >> 31672340

Complement and Coagulation: Cross Talk Through Time.

Sunny Dzik1.   

Abstract

Two complex protein defense systems-complement and coagulation-are based on amplifying enzyme cascades triggered by specific local stimuli. Excess systemic activation of either system is pathologic and is normally prevented by a family of regulatory proteins. The 2 systems are ancient biological processes which share a common origin that predates vertebrate evolution. Recent research has uncovered multiple opportunities for cross talk between complement and coagulation including proteins traditionally viewed as coagulation factors that activate and regulate complement, and proteins traditionally seen as part of the complement system that participate in coagulation. Ten examples of cross talk between the 2 systems are described. The mutual engagement of both systems is increasingly recognized to occur in human diseases. Three conditions-paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and the antiphospholipid syndrome-provide examples of the importance of interactions between complement and coagulation in human biology. A better understanding of the mutual engagement of these 2 ancient defense systems is expected to result in improved diagnostics and new treatments for systemic diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-phospholipid syndrome; Atypical hemolytic-uremic syndrome; Coagulation; Complement; Paroxysmal nocturnal hemoglobinuria

Mesh:

Substances:

Year:  2019        PMID: 31672340     DOI: 10.1016/j.tmrv.2019.08.004

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  21 in total

Review 1.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

Review 2.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

3.  In Ovo Injection of CHIR-99021 Promotes Feather Follicle Development via Modulating the Wnt Signaling Pathway and Transcriptome in Goose Embryos (Anser cygnoides).

Authors:  Ziqiang Feng; Haizhou Gong; Jinhong Fu; Xiaohui Xu; Yupu Song; Xiaomin Yan; Ichraf Mabrouk; Yuxuan Zhou; Yudong Wang; Xianou Fu; Yujian Sui; Tuoya Liu; Chuanghang Li; Zebei Liu; Xu Tian; Le Sun; Keying Guo; Yongfeng Sun; Jingtao Hu
Journal:  Front Physiol       Date:  2022-05-20       Impact factor: 4.755

Review 4.  Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.

Authors:  Alexander Fletcher-Sandersjöö; Bo-Michael Bellander
Journal:  Thromb Res       Date:  2020-06-18       Impact factor: 3.944

Review 5.  Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol.

Authors:  Alexander Fletcher-Sandersjöö; Marc Maegele; Bo-Michael Bellander
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

6.  COVID-19 Convalescent Plasma: Now Is the Time for Better Science.

Authors:  Sunny Dzik
Journal:  Transfus Med Rev       Date:  2020-04-23

Review 7.  Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis.

Authors:  Marco Mannes; Christoph Q Schmidt; Bo Nilsson; Kristina N Ekdahl; Markus Huber-Lang
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

Review 8.  Complement in Hemolysis- and Thrombosis- Related Diseases.

Authors:  Shanshan Luo; Desheng Hu; Moran Wang; Peter F Zipfel; Yu Hu
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

9.  Complement C1q Enhances Primary Hemostasis.

Authors:  Claudia Donat; Robert Kölm; Kinga Csorba; Eylul Tuncer; Dimitrios A Tsakiris; Marten Trendelenburg
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

Review 10.  Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Authors:  Scott R Barnum; Doryen Bubeck; Theresa N Schein
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.